Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct 4:5:90.
doi: 10.1186/1748-717X-5-90.

Accelerated Partial Breast Irradiation (APBI): A review of available techniques

Affiliations
Review

Accelerated Partial Breast Irradiation (APBI): A review of available techniques

Christopher F Njeh et al. Radiat Oncol. .

Abstract

Breast conservation therapy (BCT) is the procedure of choice for the management of the early stage breast cancer. However, its utilization has not been maximized because of logistics issues associated with the protracted treatment involved with the radiation treatment. Accelerated Partial Breast Irradiation (APBI) is an approach that treats only the lumpectomy bed plus a 1-2 cm margin, rather than the whole breast. Hence because of the small volume of irradiation a higher dose can be delivered in a shorter period of time. There has been growing interest for APBI and various approaches have been developed under phase I-III clinical studies; these include multicatheter interstitial brachytherapy, balloon catheter brachytherapy, conformal external beam radiation therapy and intra-operative radiation therapy (IORT). Balloon-based brachytherapy approaches include Mammosite, Axxent electronic brachytherapy and Contura, Hybrid brachytherapy devices include SAVI and ClearPath. This paper reviews the different techniques, identifying the weaknesses and strength of each approach and proposes a direction for future research and development. It is evident that APBI will play a role in the management of a selected group of early breast cancer. However, the relative role of the different techniques is yet to be clearly identified.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagrammatic illustration of multi-catheter interstitial brachytherapy.
Figure 2
Figure 2
The MammoSite Balloon applicator (courtesy of Hologic, Marlborough).
Figure 3
Figure 3
The MammoSite Multilumen System (courtesy of Hologic, Marlborough).
Figure 4
Figure 4
Axxent electronic brachytherapy, controller front view (courtesy of Xoft).
Figure 5
Figure 5
Axxent electronic brachytherapy, HDR X-ray source (courtesy of Xoft).
Figure 6
Figure 6
Axxent electronic brachytherapy, balloon applicator (courtesy of Xoft).
Figure 7
Figure 7
The Contura balloon applicator (courtesy of SenoRx).
Figure 8
Figure 8
Different sizes of SAVI with peripheral struts expanded (courtesy of Cianna Medical).
Figure 9
Figure 9
ClearPath device (a) the base detached (b) a cap placed over the HDR channels (courtesy of North America Scientific).
Figure 10
Figure 10
3D-CRT typical 4-field arrangement for right sided lesions and 5 field arrangement for left sided lesions (reprinted with permission from Baglan et al.[93].
Figure 11
Figure 11
The mobile X-ray intraoperative radiation therapy device: The Intrabeam device intraoperative photon device.
Figure 12
Figure 12
Various spherical applicators with diameters ranging from 1.5 to 5 cm used in the intrabeam device (reprinted with permission Holmes et al: [117].
Figure 13
Figure 13
The mobile electron intraoperative radiation therapy devices: (a) Novac7 (b) Mobetron intra-operative electron device (reprinted with permission Beddar el al. [124]).

References

    1. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst. 1993;85:892–897. doi: 10.1093/jnci/85.11.892. - DOI - PubMed
    1. SEER Cancer Statistics Review, 1975-2006. http://seer.cancer.gov/csr/1975_2006/
    1. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12:20–37. doi: 10.1634/theoncologist.12-1-20. - DOI - PubMed
    1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2006 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010. http://www.cdc.gov/uscs
    1. anon. Book Cancer Statistics registrations: Registrations of cancer diagnosed in 2006, England. (Editor ed.^eds.) City: National Statistics; 2009. Cancer Statistics registrations: Registrations of cancer diagnosed in 2006, England.